Document is current
Any future updates will be listed below
-
Authors
Riedl, Marc A.
Narsipur, Nihal
Jones, Douglas
Tachdjian, Raffi
Relan, Anurag
Kilvert, Hannah
Aiello, Emily
Habimana, Ketsia
Roskell, Neil
Gough, Adam
Harper, Joseph R.
Li, H. Henry
Harrington, Amanda
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00225147 at ClinicalTrials.govnct01188564 at ClinicalTrials.govDocuments that mention this clinical trial
Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary Angioedema
https://doi.org/10.1007/s12325-026-03625-0
nct00262301 at ClinicalTrials.govDocuments that mention this clinical trial
Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary Angioedema
https://doi.org/10.1007/s12325-026-03625-0
Documents that mention this clinical trial
Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary Angioedema
https://doi.org/10.1007/s12325-026-03625-0
-
Funding
Funding for this research was provided by:
Pharming Healthcare, Inc.
- License Information
-
More Information
Article History
Received: 25 February 2026
Accepted: 22 April 2026
First Online: 20 May 2026
Declarations
:
: Marc A. Riedl has received research or consulting support from or provided speaker presentations for Astria Therapeutics, BioCryst Pharmaceuticals, Inc, BioMarin Pharmaceutical, Celldex Therapeutics, CSL Behring, Cycle Pharma, Grifols, Intellia, Ionis Pharmaceuticals, Inc, KalVista Pharmaceuticals, Novartis, Pharming Healthcare, Inc., Pharvaris, Sanofi-Regeneron, and Takeda. Douglas Jones is a consultant for Pharming Healthcare, Inc., KalVista Pharmaceuticals, Takeda Pharmaceutical Company Limited, CSL Behring, BioCryst Pharmaceuticals, Inc, and Pharvaris. Raffi Tachdjian has received research or consulting support from Astria Therapeutics, BioCryst Pharmaceuticals, Inc, CSL Behring, Ionis Pharmaceuticals, Inc, Intellia, KalVista Pharmaceuticals, Pharming Healthcare, Inc., Pharvaris, and Takeda Pharmaceutical Company Limited; and provided speaker presentations for ARS Pharmaceuticals, AstraZeneca, BioCryst Pharmaceuticals, Inc, CSL Behring, Grifols, GSK, Pharming Healthcare, Inc., Sanofi-Regeneron, and Takeda Pharmaceutical Company Limited. Hannah Kilvert, Emily Aiello, Ketsia Habimana, Neil Roskell, and Adam Gough are employees of Lumanity, which received consulting fees from Pharming Healthcare, Inc. H. Henry Li has received research or consulting support from or provided speaker presentations for CSL Behring, BioCryst Pharmaceuticals, Pharvaris, Argo Biopharma, KalVista Pharmaceuticals, Takeda Pharmaceutical Company Limited, Intellia Therapeutics, Pharming Healthcare, Inc., and Ionis Pharmaceuticals, Inc. Nihal Narsipur, Anurag Relan, Joseph R. Harper, and Amanda Harrington are employees of Pharming Healthcare, Inc.
: This study is a post hoc analysis of previously conducted studies that were performed in accordance with the Helsinki Declaration of 1964 and its later amendments and does not contain any new studies with human participants performed by any of the authors, therefore ethics committee approval was not required.
